Sectors

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

Cision, already a shareholder in the social media analytics provider, is set to pay $450m to acquire it, following $63m in funding.

Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.

RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.

Sutter Health, Novo, Sentara and Health Care Service Corporation are set to exit the virtual healthcare provider in an acquisition of undisclosed size.

Midroc Europe led a round that increzased the wave energy technology developer's total equity funding to $25m.

Axel Springer has exited the advertising data technology provider, which has been bought by Rokk3r together with its Matrix Labs spinoff for $19.5m.

Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.

The pension fund will pay an undisclosed sum for a 2% stake in API Holdings, the owner of online drugstore PharmEasy backed by Ascent Health and Medi Assist.

Tencent, SoftBank and Alphabet are in line for exits after the trucking services provider confidentially filed to float in a US initial public offering sized above $1bn.